Opportunity Information: Apply for CDC RFA PS15 1503
Apply for CDC RFA PS15 1503
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Medical Monitoring Project" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.944 Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance.
- This funding opportunity was created on Sep 30, 2014 and posted on Sep 8, 2014.
- Applicants must submit their applications by Jan 8, 2015 Dates Letter of Intent (LOI) Deadline N/A Application Deadline January 8, 2015 Informational conference call for potential applicants September 17, 2014 from 2 3pm U.S. Eastern Standard Time, Toll Free 877 785 0798 Participant Passcode 1978977. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $96,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,800,000.00 in funding.
- The number of recipients for this funding is limited to 26 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- A. Eligibility Information 1. Eligible Applicants Government Organizations State or their bona fide agents (includes the District of Columbia) Local governments or their bona fide agents Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) 2. Special Eligibility Requirements N/A 3. Justification for Less than Maximum Competition The Medical Monitoring Project or MMP is a national public health surveillance program designed to collect clinical and behavioral information on those diagnosed with HIV or AIDS. Competition for MMP funds is limited to the twenty six (26) established MMP sites originally selected in 2004. These particular sites were selected to represent the HIV epidemic in the United States. Process for the selection and establishment of MMP sites has been published in a scientific journal a detailed description of the process used for selection is available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462615/pdf/TOAIDJ 6 67.pdf. The established MMP sites have enabled CDC to obtain data that represent the country as a whole starting in 2004. Ascertainment of representative national data is the goal of MMP. Twenty States or territories, including six jurisdictions which are separately funded for other HIV/AIDS program activities within states, were selected to participate in MMP in 2004. These 26 sites have built the capacity to successfully perform MMP and enable CDC to meet surveillance goals by producing national estimates characterizing the US epidemic. The selected sites were California Department of Health Services Chicago Department of Public Health Delaware Department of Health and Social Services Florida Department of Health Georgia Department of Public Health Houston Department of Health and Human Services Illinois Department of Public Health Indiana State Department of Health Los Angeles County Health Department Maryland Department of Health and Mental Hygiene Massachusetts Department of Public Health Michigan Department of Community Health Mississippi Department of Health New Jersey Department of Health and Senior Services New York City Department of Health and Mental Hygiene New York State Department of Health North Carolina Department of Health and Human Services Oregon Department of Human Services Pennsylvania Department of Health Philadelphia Department of Public Health Puerto Rico Health Department San Francisco Department of Public Health South Carolina Department of Health and Environmental Control Texas Department of State Health Services Virginia Department of Health and Washington State Department of Health. These are the twenty six areas eligible to apply and continue to conduct MMP activities. In order to appropriately use MMP data for prevention and to evaluate national HIV related health care initiatives including portions of the Affordable Care Act, the data collected in MMP must be nationally representative. If competition is not limited to the 26 established sites listed above, MMP would not be adhering to the scientific sampling strategy chosen for its project design. Without this adherence, MMP data would not be nationally representative and would no longer produce reports that represent the HIV epidemic in the United States.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Medical Monitoring Project (MMP) grant opportunity (Funding Opportunity Number CDC RFA PS15-1503) is a CDC discretionary cooperative agreement designed to support an ongoing public health surveillance system focused on adults diagnosed with HIV in the United States. MMP uses a probability sampling approach to collect both local and nationally representative data, meaning the results are intended to describe not only participating jurisdictions but also the broader U.S. HIV-diagnosed adult population. The purpose of the project is to generate reliable, actionable information that can shape HIV prevention, care, and treatment strategies at both local and national levels.
At the core of MMP is the routine collection of information on sociodemographic factors (such as age, race/ethnicity, gender, and other relevant background characteristics), behavioral and clinical characteristics, supportive service needs, the use of healthcare and prevention services, and how well clinical care aligns with established guidelines. In practical terms, MMP helps public health agencies understand patterns like access to care, retention in care, treatment use, adherence-related measures, and unmet needs that may affect health outcomes. These data, along with related MMP-associated efforts, are intended to inform decision-making and guide responses to the HIV epidemic, including evaluating and supporting national healthcare initiatives and policy changes.
This funding announcement was posted on September 8, 2014, with an application deadline of January 8, 2015 (no letter of intent required). CDC also hosted an informational conference call for prospective applicants on September 17, 2014. The award mechanism is a cooperative agreement, which generally indicates substantial involvement by CDC in project oversight, technical assistance, and coordination to ensure consistency with national surveillance objectives and methods.
The opportunity anticipated 26 awards, reflecting the structure of MMP as a fixed network of established surveillance sites. The estimated total funding amount was $96,000,000, with an award floor of $300,000 and an award ceiling of $1,800,000. There was no cost sharing or matching requirement. The program is listed under CFDA 93.944 (HIV/AIDS Surveillance) and falls under the health funding activity category.
Eligibility for this particular competition was intentionally limited. While the eligible applicant types are government organizations (states, local governments, and territorial governments or their bona fide agents, including jurisdictions such as Puerto Rico, Guam, and others), CDC restricted competition to the 26 MMP sites originally selected in 2004. The justification for limiting competition is scientific and methodological: MMP was designed around a specific sampling strategy, and maintaining a stable set of participating jurisdictions is necessary for producing nationally representative estimates over time. Expanding eligibility beyond the established sites would disrupt the sampling framework and could undermine the ability of MMP to generate national-level surveillance results that accurately represent the U.S. HIV epidemic.
The 26 established and eligible jurisdictions named in the announcement include a mix of states, cities, and territories that together were selected to represent the U.S. epidemic, such as California, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Mississippi, New Jersey, New York State, North Carolina, Oregon, Pennsylvania, South Carolina, Texas, Virginia, Washington, Puerto Rico, and several major city/county health departments including Chicago, Houston, Los Angeles County, New York City, Philadelphia, and San Francisco. These jurisdictions have built the operational capacity to implement the project consistently and contribute data that can be rolled up into national estimates.
For administrative support, the announcement directs applicants who have trouble accessing the full opportunity to contact the CDC Procurement and Grants Office Technical Information Management Section (TIMS) by phone (770-488-2700) or email (pgotim@cdc.gov).
Frequently Asked Questions (FAQ) - Medical Monitoring Project (MMP) Grant (CDC RFA PS15-1503)
1) What is the Medical Monitoring Project (MMP) grant opportunity?
The Medical Monitoring Project (MMP) grant opportunity (Funding Opportunity Number CDC RFA PS15-1503) is a CDC discretionary cooperative agreement that supports an ongoing public health surveillance system focused on adults diagnosed with HIV in the United States.
2) What is the purpose of MMP?
The purpose of MMP is to generate reliable, actionable information that can shape HIV prevention, care, and treatment strategies at both local and national levels. The data are intended to support decision-making and guide responses to the HIV epidemic, including evaluating and supporting national healthcare initiatives and policy changes.
3) What does MMP measure or collect data on?
MMP routinely collects information on:
- Sociodemographic factors (for example age, race/ethnicity, gender, and other background characteristics)
- Behavioral characteristics
- Clinical characteristics
- Supportive service needs
- Use of healthcare and prevention services
- How well clinical care aligns with established guidelines
4) Who is the population MMP focuses on?
MMP is focused on adults diagnosed with HIV in the United States.
5) How does MMP produce both local and national results?
MMP uses a probability sampling approach to collect data that are intended to be locally representative for participating jurisdictions and nationally representative for the broader U.S. HIV-diagnosed adult population.
6) Why is probability sampling important for this project?
Probability sampling is central to MMP because it supports the production of nationally representative estimates over time. The grant description emphasizes that changing the participating jurisdictions could disrupt the sampling framework and undermine the ability to generate national-level surveillance results.
7) What kinds of public health questions can MMP data help answer?
Based on the description, MMP helps public health agencies understand patterns related to access to care, retention in care, treatment use, adherence-related measures, and unmet needs that may affect health outcomes, as well as the extent to which clinical care aligns with established guidelines.
8) What type of award mechanism is used for this funding opportunity?
The award mechanism is a cooperative agreement.
9) What does it mean that this opportunity is a cooperative agreement?
The announcement notes that a cooperative agreement generally indicates substantial involvement by CDC in project oversight, technical assistance, and coordination to ensure consistency with national surveillance objectives and methods.
10) When was this funding announcement posted?
The funding announcement was posted on September 8, 2014.
11) What was the application deadline?
The application deadline was January 8, 2015.
12) Was a letter of intent required?
No letter of intent was required.
13) Did CDC host an informational call for applicants?
Yes. CDC hosted an informational conference call for prospective applicants on September 17, 2014.
14) How many awards were anticipated?
The opportunity anticipated 26 awards, aligned with MMP being a fixed network of established surveillance sites.
15) What was the estimated total funding amount?
The estimated total funding amount was $96,000,000.
16) What were the award floor and award ceiling?
The award floor was $300,000 and the award ceiling was $1,800,000.
17) Was cost sharing or matching required?
No. There was no cost sharing or matching requirement.
18) What CFDA program is associated with this opportunity?
The program is listed under CFDA 93.944, HIV/AIDS Surveillance.
19) What funding activity category does this opportunity fall under?
The announcement identifies the opportunity as falling under the health funding activity category.
20) Who was eligible to apply?
Eligible applicant types were government organizations (states, local governments, and territorial governments or their bona fide agents, including jurisdictions such as Puerto Rico and Guam). However, eligibility was further restricted for this competition.
21) Was eligibility open to all states and localities?
No. CDC restricted competition to the 26 MMP sites originally selected in 2004.
22) Why was the competition limited to the original 26 MMP sites?
The announcement explains that the limitation is scientific and methodological. MMP was designed around a specific sampling strategy, and maintaining a stable set of participating jurisdictions is necessary for producing nationally representative estimates over time. Expanding eligibility beyond the established sites would disrupt the sampling framework and could undermine national-level representativeness.
23) Which jurisdictions were included among the eligible established MMP sites?
The announcement lists eligible jurisdictions including a mix of states, cities, and territories. Examples named include California, Florida, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Mississippi, New Jersey, New York State, North Carolina, Oregon, Pennsylvania, South Carolina, Texas, Virginia, Washington, Puerto Rico, and several major city/county health departments including Chicago, Houston, Los Angeles County, New York City, Philadelphia, and San Francisco.
24) How does CDC describe the role of these established jurisdictions in MMP?
The description notes that these jurisdictions were selected to represent the U.S. epidemic and have built the operational capacity to implement the project consistently and contribute data that can be rolled up into national estimates.
25) What should applicants do if they have trouble accessing the full opportunity announcement?
Applicants who have trouble accessing the full opportunity are directed to contact the CDC Procurement and Grants Office Technical Information Management Section (TIMS) by phone at 770-488-2700 or by email at pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 4 Tennessee (entire state)
Previous opportunity: FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 4 South Carolina (entire state)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS15 1503
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS15 1503) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 4 Tennessee (entire state) Apply for PA FPH 15 013 Funding Number: PA FPH 15 013 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $6,707,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 5 Illinois (entire state) Apply for PA FPH 15 014 Funding Number: PA FPH 15 014 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $7,980,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 5 Minnesota (Ramsey County) Apply for PA FPH 15 015 Funding Number: PA FPH 15 015 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $441,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 5 Ohio Apply for PA FPH 15 018 Funding Number: PA FPH 15 018 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,837,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 5 Wisconsin (entire state) Apply for PA FPH 15 019 Funding Number: PA FPH 15 019 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,538,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 6 Oklahoma (entire state) Apply for PA FPH 15 020 Funding Number: PA FPH 15 020 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,444,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region VI New Mexico (entire state) Apply for PA FPH 15 021 Funding Number: PA FPH 15 021 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,304,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 7 Kansas (entire state) Apply for PA FPH 15 023 Funding Number: PA FPH 15 023 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,522,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 6 Texas (entire state) Apply for PA FPH 15 022 Funding Number: PA FPH 15 022 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $13,947,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 9 California (East Los Angeles) Apply for PA FPH 15 025 Funding Number: PA FPH 15 025 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $480,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 9 Guam (entire territory) Apply for PA FPH 15 026 Funding Number: PA FPH 15 026 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $290,000 |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 7 Nebraska (entire state) Apply for PA FPH 15 024 Funding Number: PA FPH 15 024 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,072,000 |
| HIV Early Intervention Services Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 15 027 Funding Number: HRSA 15 027 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY15 Announcement of Anticipated Availability of Funds for Family Planning Services Grants Region 9 Republic of the Marshall Islands (entire RMI) Apply for PA FPH 15 027 Funding Number: PA FPH 15 027 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $129,000 |
| Strengthening Local University Capacity to Provide Quality Medical Education and HIV Prevention, Care and Treatment in Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1523 Funding Number: CDC RFA GH15 1523 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1515 Funding Number: CDC RFA GH15 1515 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Service Area Competition Additional Area (SAC AA) Hollis, OK and Oakland, CA Apply for HRSA 15 120 Funding Number: HRSA 15 120 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (SAC AA) Brooklyn, NY Apply for HRSA 15 122 Funding Number: HRSA 15 122 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Secondary Analyses of Existing Alcohol Epidemiology Data (R21) Apply for PA 14 336 Funding Number: PA 14 336 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Secondary Analyses of Existing Alcohol Epidemiology Data (R03) Apply for PA 14 337 Funding Number: PA 14 337 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS15 1503", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.